GlaxoSmithKline Newsroom

GSK (GSK.US) monoclonal antibody first-line therapy has received FDA breakthrough therapy designation for the treatment of rectal cancer.

The USA FDA has granted Breakthrough Therapy Designation (BTD) to its PD-1 inhibitor Jemperli (dostarlimab) for the treatment of locally advanced mismatch repair-deficient (dMMR)/high microsatellite instability (MSI-H) colorectal cancer.

Zhitong Finance08:17 ET

Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts

Benzinga14:45 ET

Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana

Benzinga11:08 ET

Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers

GlobeNewswireDec 18 08:45 ET

Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges

TipRanksDec 18 05:46 ET · Ratings

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT NewswiresDec 17 10:57 ET

GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli

Zacks Dec 17 10:05 ET

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TipRanksDec 17 08:25 ET · Ratings

What's Going On Moderna Stock On Monday?

BenzingaDec 16 13:10 ET

GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer

MT NewswiresDec 16 09:21 ET

GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK

Proactive InvestorsDec 16 03:18 ET

GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA

MT NewswiresDec 16 02:42 ET

GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

WSJDec 16 02:37 ET

ViiV Healthcare Announces CHMP Positive Opinion for Vocabria + Rekambys, the First and Only Complete Long-acting HIV Treatment, for Adolescents in Europe

GSK PlcDec 16 00:00 ET

Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer

GSK PlcDec 16 00:00 ET

GSK's B7-H3-targeted Antibody-drug Conjugate, GSK'227, Receives EMA Priority Medicines (PRIME) Designation in Relapsed Extensive-stage Small-cell Lung Cancer

GSK PlcDec 16 00:00 ET

Jemperli (Dostarlimab) Receives US FDA Breakthrough Therapy Designation for Locally Advanced DMMR/MSI-H Rectal Cancer

GSK PlcDec 16 00:00 ET

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis

BenzingaDec 13 11:06 ET

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

BenzingaDec 12 13:13 ET

Barclays Remains a Hold on GlaxoSmithKline (GSK)

TipRanksDec 12 02:35 ET · Ratings